InflaRx NV (IFRX)
1.30
0.00 (0.00%)
USD |
NASDAQ |
Nov 09, 16:00
1.30
0.00 (0.00%)
After-Hours: 18:43
InflaRx Gross Profit (Annual) : -8.612M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -8.612M |
| December 31, 2024 | -3.901M |
| December 31, 2023 | -1.056M |
| December 31, 2022 | -0.627M |
| December 31, 2021 | -0.7913M |
| December 31, 2020 | -0.8125M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.7422M |
| December 31, 2018 | -0.2053M |
| December 31, 2017 | -0.0801M |
| December 31, 2016 | -0.0376M |
| December 31, 2015 | -0.0444M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 2.515B |
| Immatics NV | 0.00 |
| Arrowhead Pharmaceuticals, Inc. | 805.52M |
| Oncolytics Biotech, Inc. | -0.07M |